Rheumatic Diseases Completed Phase 3 Trials for Cyclobenzaprine (DB00924)

Also known as: Rheumatic Disease / Rheumatism, unspecified / Rheumatics / Rheumatism (disorder) / Rheumatism

IndicationStatusPhase
DBCOND0027857 (Rheumatic Diseases)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02436096A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgiaTreatment